Cannabics Pharmaceuticals Receives Cannabinoid R&D Lab Certification in Israel

Source: Cannabics Pharmaceuticals, Inc. Press Release 10.20.14   BETHESDA, MD–(Marketwired – Oct 20, 2014) – Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that it has received Government Certification from the Ministry of Health in Israel for the establishment of an advanced R&D laboratory dedicated to medical research in the field of cannabinoid science. The stated…

The post Cannabics Pharmaceuticals Receives Cannabinoid R&D Lab Certification in Israel appeared first on Marijuana Index.